🤯 Have you seen our AI stock pickers’ 2024 results? 84.62%! Grab November’s list now.Pick Stocks with AI

West Pharmaceutical Services Inc (WST)

NYSE
Currency in USD
316.50
+8.57(+2.78%)
Closed
After Hours
316.500.00(0.00%)

WST Income Statement

Advanced Income Statement
Period Ending:
2014
31/12
2015
31/12
2016
31/12
2017
31/12
2018
31/12
2019
31/12
2020
31/12
2021
31/12
2022
31/12
2023
31/12
Total Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa1,839.92,146.92,831.62,886.92,949.8
Total Revenues Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+7.13%+16.69%+31.89%+1.95%+2.18%
Cost Of Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa1,234.21,379.11,653.91,750.71,819.8
Gross Profit
aa.aaaa.aaaa.aaaa.aaaa.aa605.7767.81,177.71,136.21,130
Gross Profit Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+11.06%+26.76%+53.39%-3.52%-0.55%
Gross Profit Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa32.92%35.76%41.59%39.36%38.31%
Other Operating Expenses, Total
aa.aaaa.aaaa.aaaa.aaaa.aa309.7345.2404.8368.9419.5
Other Operating Expenses, Total Growth
R&D Expenses
Selling General & Admin Expenses
Other Operating Expenses
aa.aaaa.aaaa.aaaa.aaaa.aa+5.16%+11.46%+17.27%-8.87%+13.72%
aa.aaaa.aaaa.aaaa.aaaa.aa38.946.952.858.568.4
aa.aaaa.aaaa.aaaa.aaaa.aa272.8300.8356.3316354.1
aa.aaaa.aaaa.aaaa.aaaa.aa-2-2.5-4.3-5.6-3
Operating Income
aa.aaaa.aaaa.aaaa.aaaa.aa296422.6772.9767.3710.5
Operating Income Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+17.98%+42.77%+82.89%-0.72%-7.4%
EBIT Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa16.09%19.68%27.3%26.58%24.09%
Net Interest Expenses
aa.aaaa.aaaa.aaaa.aaaa.aa-4.7-6.8-7.2-2.819
Net Interest Expenses Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+25.4%-44.68%-5.88%+61.11%+778.57%
Interest Expense, Total
aa.aaaa.aaaa.aaaa.aaaa.aa-8.5-8.2-8.2-7.9-9
Interest And Investment Income
aa.aaaa.aaaa.aaaa.aaaa.aa3.81.415.128
Other Non Operating Expenses, Total
aa.aaaa.aaaa.aaaa.aaaa.aa13.518.921.524.88.3
EBT, Excl. Unusual Items
aa.aaaa.aaaa.aaaa.aaaa.aa304.8434.7787.2789.3737.8
Gain (Loss) On Sale Of Assets
aa.aaaa.aaaa.aaaa.aaaa.aa-----11.6
Other Unusual Items, Total
aa.aaaa.aaaa.aaaa.aaaa.aa-1.1-8.9-11.7-61.4-8.2
EBT, Incl. Unusual Items
aa.aaaa.aaaa.aaaa.aaaa.aa300.7418.7769700.6715.7
EBT, Incl. Unusual Items Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+21.1%+39.24%+83.66%-8.89%+2.16%
EBT, Incl. Unusual Items Margin
aa.aaaa.aaaa.aaaa.aaaa.aa16.34%19.5%27.16%24.27%24.26%
Income Tax Expense
aa.aaaa.aaaa.aaaa.aaaa.aa5972.5107.2114.7122.3
Net Income to Company
aa.aaaa.aaaa.aaaa.aaaa.aa241.7346.2661.8585.9593.4
Minority Interest
aa.aaaa.aaaa.aaaa.aaaa.aa-----
Net Income
aa.aaaa.aaaa.aaaa.aaaa.aa241.7346.2661.8585.9593.4
Net Income Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+16.82%+43.24%+91.16%-11.47%+1.28%
Net Income Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa13.14%16.13%23.37%20.3%20.12%
Preferred Dividend and Other Adjustments
aa.aaaa.aaaa.aaaa.aaaa.aa-----
Net Income to Common Excl. Extra Items
aa.aaaa.aaaa.aaaa.aaaa.aa241.7346.2661.8585.9593.4
Basic EPS - Continuing Operations
aa.aaaa.aaaa.aaaa.aaaa.aa3.274.688.97.887.99
Basic EPS - Continuing Operations Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+16.66%+43.43%+89.88%-11.47%+1.42%
Diluted EPS - Continuing Operations
aa.aaaa.aaaa.aaaa.aaaa.aa3.214.578.677.737.88
Diluted EPS - Continuing Operations Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+17.15%+42.37%+89.72%-10.84%+1.94%
Basic Weighted Average Shares Outstanding
aa.aaaa.aaaa.aaaa.aaaa.aa7473.974.474.474.3
Diluted Weighted Average Shares Outstanding
aa.aaaa.aaaa.aaaa.aaaa.aa75.475.876.375.875.3
Dividend Per Share
aa.aaaa.aaaa.aaaa.aaaa.aa0.610.650.690.730.77
Dividend Per Share Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+7.02%+6.56%+6.15%+5.8%+5.48%
EBITDA
aa.aaaa.aaaa.aaaa.aaaa.aa399.4531.7895.2887.9847.8
EBITDA Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+12.41%+33.12%+68.37%-0.82%-4.52%
EBITDA Margin %
aa.aaaa.aaaa.aa